Treatment with lipoprotein apheresis is associated with significant decrease of biomarkers related to endothelial dysfunction and inflammation not only after each procedure but in the long-term follow-up of up to 15 years, in both HeFH and HoFH patients

Autor: Blaha, V., Blaha, M., Lánská, M., Andrýs, C., Tebbens, J.D., Sá, I. C. Igreja, Tripská, K., Vicen, M., Víšek, J., Lášticová, M., Nachtigal, P.
Zdroj: In Atherosclerosis August 2021 331:e135-e136
Databáze: ScienceDirect